Sale!

TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the TGFB3 gene that are associated with Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 (ARVC1). ARVC1 is a form of heart disease characterized by the replacement of heart muscle with fatty and fibrous tissue, primarily affecting the right ventricle. This condition can lead to heart rhythm problems, heart failure, and an increased risk of sudden cardiac death, especially in young athletes.

The genetic test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any mutations in the TGFB3 gene that are linked to ARVC1. This test is crucial for individuals with a family history of ARVC1 or those who exhibit symptoms related to the condition, as early detection can lead to timely and potentially life-saving interventions.

The cost of the TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the specialized analysis involved, the price reflects the comprehensive nature of this genetic screening. Identifying at-risk individuals through this test allows for the implementation of preventive measures, lifestyle adjustments, and monitoring strategies to manage the condition effectively and reduce the risk of complications.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test

At DNA Labs UAE, we offer the TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test. This test helps in the diagnosis of a genetic disorder that affects the heart muscle known as Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 (ARVC1).

Test Details

ARVC1 is characterized by abnormal heart rhythms (arrhythmias) and the replacement of normal heart muscle tissue with fatty or fibrous tissue in the right ventricle. The TGFB3 gene, also known as Transforming Growth Factor Beta 3, is one of the genes associated with ARVC1. Mutations in this gene can lead to the development of the condition.

The TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test uses Next-Generation Sequencing (NGS) technology, which allows for the simultaneous analysis of multiple genes. In the context of ARVC1, NGS can be used to identify mutations in the TGFB3 gene, as well as other genes known to be associated with the condition.

Test Components and Price

The cost of the TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test is AED 4400.0. The test requires a sample of either blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

The report for the TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test is typically delivered within 3 to 4 weeks. The test is conducted using NGS technology.

Test Type and Doctor

The TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is performed by a cardiologist in the Genetics department.

Pre Test Information

Before undergoing the TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the condition.

Test Procedure

The TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test involves obtaining a DNA sample from the individual being tested. This is usually done through a blood or saliva sample. The DNA sample is then sequenced using NGS technology to identify any mutations or variations in the TGFB3 gene.

Benefits of Genetic Testing

Genetic testing for ARVC1, including the TGFB3 gene, can be beneficial for individuals with a family history of the condition or those who have symptoms suggestive of ARVC1. It can help with early diagnosis, risk assessment, and management of the condition.

Genetic Counseling

Before and after undergoing genetic testing, it is often recommended to seek genetic counseling. This allows for a discussion of the implications of the test results and any potential treatment options or preventive measures.

Test Name TGFB3 Gene Arrhythmogenic right ventricular cardiomyopathy type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TGFB3 Gene Arrhythmogenic right ventricular cardiomyopathy type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TGFB3 Gene Arrhythmogenic right ventricular cardiomyopathy type 1 NGS Genetic DNA Test gene TGFB3
Test Details

Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVC1) is a genetic disorder that affects the heart muscle. It is characterized by abnormal heart rhythms (arrhythmias) and the replacement of normal heart muscle tissue with fatty or fibrous tissue in the right ventricle.

The TGFB3 gene, also known as Transforming Growth Factor Beta 3, is one of the genes associated with ARVC1. Mutations in this gene can lead to the development of the condition.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes. In the context of ARVC1, NGS can be used to identify mutations in the TGFB3 gene, as well as other genes known to be associated with the condition.

A TGFB3 gene NGS genetic test involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the TGFB3 gene. The results of the test can help confirm a diagnosis of ARVC1 and provide information about the specific genetic variant present.

Genetic testing for ARVC1, including the TGFB3 gene, can be beneficial for individuals with a family history of the condition or those who have symptoms suggestive of ARVC1. It can help with early diagnosis, risk assessment, and management of the condition. Genetic counseling is often recommended before and after genetic testing to discuss the implications of the results and any potential treatment options or preventive measures.